Variant report
Variant | nsv432585 |
---|---|
Chromosome Location | chr4:22017218-22070731 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:22022641..22025613-chr4:22031377..22033219,2 | K562 | blood: | |
2 | chr4:22045762..22048489-chr4:22082694..22085288,2 | MCF-7 | breast: | |
3 | chr4:22028111..22029824-chr4:22035660..22037244,2 | MCF-7 | breast: | |
4 | chr4:22022641..22025613-chr4:22031377..22033219,2 | K562 | blood: | |
5 | chr4:22028111..22029824-chr4:22035660..22037244,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PACRGL-5 | chr4:22060696-22060983 | ENSG00000250039.2 |
2 | lnc-PACRGL-5 | chr4:22060707-22060983 | ENSG00000250039.3 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532777667 | chr4:22022618-22022619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs184110734 | chr4:22022641-22022642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561172158 | chr4:22022660-22022661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs572586524 | chr4:22022696-22022697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533809916 | chr4:22022700-22022701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs199977407 | chr4:22022704-22022705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369734362 | chr4:22022705-22022706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565011401 | chr4:22022716-22022717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531961857 | chr4:22022756-22022757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550562623 | chr4:22022811-22022812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562633886 | chr4:22022842-22022843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28561804 | chr4:22022857-22022858 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs188601714 | chr4:22022890-22022891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34512134 | chr4:22022924-22022925 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs181440455 | chr4:22022945-22022946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546750843 | chr4:22022955-22022956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140169321 | chr4:22022957-22022958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538646684 | chr4:22022990-22022991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555180388 | chr4:22022992-22022993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs9684525 | chr4:22023002-22023003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575509319 | chr4:22023036-22023037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536581207 | chr4:22023069-22023070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534722705 | chr4:22023152-22023153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9997381 | chr4:22023205-22023206 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs1398829 | chr4:22023275-22023276 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs540427555 | chr4:22023276-22023277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185180123 | chr4:22023310-22023311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190476310 | chr4:22023344-22023345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543863849 | chr4:22023349-22023350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs4697260 | chr4:22023350-22023351 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs530002370 | chr4:22023363-22023364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368669169 | chr4:22025223-22025224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374166018 | chr4:22025237-22025238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557989523 | chr4:22025238-22025239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs111282603 | chr4:22025239-22025240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543207744 | chr4:22025248-22025249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs369346442 | chr4:22025252-22025253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574580395 | chr4:22025257-22025258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs114496678 | chr4:22025286-22025287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs75460951 | chr4:22025307-22025308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs527639423 | chr4:22025354-22025355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570563351 | chr4:22025389-22025390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs368297725 | chr4:22025400-22025401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34444731 | chr4:22025437-22025438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs376106741 | chr4:22025462-22025463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552298122 | chr4:22025463-22025464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564792094 | chr4:22025476-22025477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192270473 | chr4:22025485-22025486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538430557 | chr4:22025503-22025504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs183997463 | chr4:22025539-22025540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Cancer | 22183965 | CNVD |
Gastric cancer | 16891809 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:22022600-22023400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr4:22025200-22025600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr4:22028600-22028800 | Enhancers | H9 Cell Line | embryonic stem cell |
4 | chr4:22028800-22029000 | ZNF genes & repeats | H9 Cell Line | embryonic stem cell |
5 | chr4:22031000-22032000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr4:22031000-22032200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr4:22031200-22032400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr4:22031600-22031800 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
9 | chr4:22031600-22032000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr4:22031600-22032200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr4:22031800-22032000 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
12 | chr4:22031800-22032200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr4:22045200-22046000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr4:22046200-22047400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr4:22059800-22066400 | Weak transcription | Pancreas | Pancrea |
16 | chr4:22060800-22062200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
17 | chr4:22062200-22063200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
18 | chr4:22063200-22066400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
19 | chr4:22066400-22066600 | ZNF genes & repeats | Pancreas | Pancrea |
20 | chr4:22066400-22073200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |